ACS Global, Inc.
Not enough financial coverage to compute a composite score for AMCY. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.americancryostem.com
ACS Global, Inc. engages in the collection, processing, and long-term storage of stem cells. The company's services would allow individuals to privately preserve their stem cells for potential future use in cell therapy.
- CEO
- Anthony Francis Dudzinski Jr.
- IPO
- 2021
- HQ
- Red Bank, NJ, US
Price Chart
Performance & Tape
- 52W High
- $3.00
- 52W Low
- $3.00
- 50D MA
- $3.00
- 200D MA
- $3.00
- Beta
- 0.00
- Avg Volume
- 0
Get TickerSpark's AI analysis on AMCY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AMCY Coverage
We haven't published any research on AMCY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMCY Report →